Results 51 to 60 of about 6,464 (211)
Food Science &Nutrition, Volume 14, Issue 7, July 2026.Marine‐derived biosurfactants produced by microorganisms (including bacteria, fungi, and yeast) have amphiphilic properties that facilitate membrane interactions and transport across the blood–brain barrier (BBB). These biosurfactants exhibit neuroprotective activity by targeting mechanisms implicated in Alzheimer's disease, including reducing ...
Zainab Irfan +4 more
wiley +1 more source
Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates [PDF]
, 2022 BACKGROUND: Increased fluconazole and echinocandin resistance in Candida glabrata requires prompt detection in routine settings. A phenotypic test based on the EUCAST E.DEF 7.3.2 protocol was developed for the detection of fluconazole- and anidulafungin ...
Meletiadis, Joseph +2 more
core +1 more source
Therapeutic Advances in Infectious DiseaseBackground: Echinocandins are recommended as an initial treatment for invasive candidiasis. Although safety and efficacy profiles of both anidulafungin and caspofungin are well established, direct head-to-head comparisons have not been reported before ...
Reem Hasan Elajez +10 more
doaj +1 more source
Journal of Fungi, 2023 Candida auris is an emerging fungal pathogen responsible for hospital outbreaks of invasive candidiasis associated with high mortality. The treatment of these mycoses is a clinical challenge due to the high resistance levels of this species to current ...
Iñigo de-la-Fuente +5 more
doaj +1 more source
Epicardial Lead Dysfunction in a Patient With Mechanical Tricuspid Valve—A Challenging Complication
Annals of Noninvasive Electrocardiology, Volume 31, Issue 4, July 2026.Panel 1: Clinical presentation Patient profile: A 51‐year‐old female with a history of mechanical mitral and tricuspid valve replacements. Clinical condition: Development of complete atrioventricular (AV) block and subsequent epicardial lead dysfunction. Symptoms: Admission with dizziness, syncope, and fatigue.
Tuba Guctekin, Mucahit Yasin Guctekin
wiley +1 more source
Filter Adsorption of Anidulafungin to a Polysulfone-Based Hemofilter During CVVHD In Vitro [PDF]
, 2017 Candidemia is frequent in critically ill patients, especially in combination with an acute kidney injury (AKI). Echinocandins generally are recommended for therapy of such infections.
Michael Gruber +9 more
core +1 more source
Mycoses, Volume 69, Issue 7, July 2026.ABSTRACT Background The efficacy and safety of rezafungin in invasive candidiasis (IC) and candidaemia was demonstrated in the Phase 2 STRIVE and Phase 3 ReSTORE trials, and an additional cohort of patients in ReSTORE from China (ReSTORE China). Objectives This post hoc analysis is the first time that combined data from all double‐blind, randomised ...
Alex Soriano +12 more
wiley +1 more source
Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey [PDF]
, 2017 Anidulafungin has been shown to be non-inferior to, and possibly more efficacious, than fluconazole in treating patients with invasive candidiasis (IC). This study aimed to determine the cost-effectiveness of anidulafungin vs fluconazole for treatment of
Turner, Stuart J. +11 more
core +1 more source
Southern African Journal of Infectious Diseases, 2023 Background: Worldwide, the leading cause of invasive candidiasis and the fourth leading cause of hospital-acquired infections are the Candida species (spp.) group.
Anja Grey +3 more
doaj +1 more source
Peer review of the pesticide risk assessment of the active substance Trichoderma atroviride 77B
EFSA Journal, Volume 24, Issue 7, July 2026.Abstract The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, the Netherlands, for the pesticide active substance Trichoderma atroviride 77B and the considerations as regards the inclusion of the substance in Annex IV of Regulation (EC) No 396/2005 ...
European Food Safety Authority (EFSA) +48 more
wiley +1 more source